ArticleBMC women's health2025
Validation of a measure of contraceptive self-injection self-efficacy in Uganda.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundSexual and reproductive health self-care interventions, including self-administered injectable contraception, can promote individual agency and health. As an increasing number of programs seek to introduce and expand access to self-injectable contraception, it’s imperative to develop measures that define programmatic success based on whether people have the opportunity to make a decision about self-injectable use with agency, rather than relying on measures of self-injectable uptake.
methodsWe performed psychometric evaluation to validate a self-injectable self-efficacy scale using cross-sectional survey data collected among 2,369 sexually active, reproductive aged women in Uganda. We examined descriptive statistics of a pool of five potential items before conducting an Exploratory Factor Analysis to determine factor structure and reduce the item pool. We ran a Confirmatory Factor Analysis to confirm the factor structure and performed a correlation analysis to determine whether the final self-injectable self-efficacy scale was correlated with items related to contraceptive decision-making self-efficacy and previous self-injectable use.
resultsOur final measure of self-injectable self-efficacy is a unidimensional scale that contains three items: 1) “I feel confident that I could self-inject on my own at the end of training,” 2) “I feel confident that I can do all the steps correctly and will be protected from pregnancy,” and 3) “I can manage to self-inject even if I feel very scared at first.” Self-injectable self-efficacy was positively and significantly correlated with prior self-injectable use and items related to contraceptive decision-making self-efficacy.
conclusionWe validated a novel self-care focused measure of self-injectable self-efficacy in Uganda. Self-injectable self-efficacy, which can be measured among all reproductive-aged women regardless of prior self-injectable training or use, can be used to evaluate self-injectable programs to determine whether programs equip people with the tools needed to successfully use self-injectable contraception if they desire.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.